FDA delays decision on new Alzheimer's drug
by Robin FosterInstead of approving the new Alzheimer's drug donanemab this month, as was expected, the U.S. Food and Drug Administration will now require the experimental medication be scrutinize
Updated on: March 20,2024
11
FDA delays decision on new Alzheimer's drug
by Robin FosterInstead of approving the new Alzheimer's drug donanemab this month, as was expected, the U.S. Food and Drug Administration will now require the experimental medication be scrutinize
Updated on:March 20,2024
11